HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Milica Radojković Selected Research

Milica Radojković Research Topics

Disease

2Lymphoma (Lymphomas)
03/2011 - 01/2011
1Hematologic Neoplasms (Hematological Malignancy)
01/2019
1Acute Erythroblastic Leukemia (Erythroleukemia)
01/2019
1Neoplasms (Cancer)
11/2015
1Back Pain (Backache)
09/2013
1Leukocytosis (Pleocytosis)
09/2013
1Multiple Myeloma
09/2013
1Essential Thrombocythemia
09/2013
1Thrombocytosis (Thrombocythemia)
09/2013
1Body Weight (Weight, Body)
05/2011
1Systemic Mastocytosis
05/2011
1Splenomegaly
03/2011
1Lymphadenopathy
03/2011
1Carcinoma (Carcinomatosis)
01/2011
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2011

Drug/Important Bio-Agent (IBA)

1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1Hydroxyurea (Hydrea)FDA LinkGeneric
01/2019
1purineIBA
11/2015
1anagrelide (Agrylin)FDA LinkGeneric
09/2013
1Pharmaceutical PreparationsIBA
09/2013
1Hemoglobins (Hemoglobin)IBA
09/2013
1CladribineFDA LinkGeneric
05/2011
1Prednisone (Sone)FDA LinkGeneric
03/2011
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2011
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2011
1Vincristine (Oncovin)FDA LinkGeneric
03/2011
1Immunoglobulin M (IgM)IBA
01/2011

Therapy/Procedure

2Therapeutics
01/2019 - 05/2011
1CHOP protocol (VDCP protocol)
03/2011
1Drug Therapy (Chemotherapy)
03/2011
1Aftercare (After-Treatment)
01/2011